ChartMill assigns a Buy % Consensus number of 84% to SION. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-14 | BTIG | Reiterate | Buy -> Buy |
| 2026-01-07 | BTIG | Maintains | Buy -> Buy |
| 2025-12-23 | LifeSci Capital | Initiate | Outperform |
| 2025-12-01 | RBC Capital | Downgrade | Sector Perform -> Underperform |
| 2025-11-19 | BTIG | Initiate | Buy |
| 2025-10-17 | Freedom Capital Markets | Initiate | Buy |
| 2025-09-08 | Jones Trading | Initiate | Buy |
| 2025-09-03 | RBC Capital | Initiate | Sector Perform |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-03-04 | Stifel | Initiate | Buy |
14 analysts have analysed SION and the average price target is 45.75 USD. This implies a price increase of 9.54% is expected in the next year compared to the current price of 41.77.
The consensus rating for SIONNA THERAPEUTICS INC (SION) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering SIONNA THERAPEUTICS INC (SION) is 14.